pyridoxal phosphate has been researched along with Disease Exacerbation in 6 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of a nucleotidase-resistant agonist confers a beneficial effect in the CSQ model of heart failure, apparently via an activation of the cardiac P2X receptor." | 1.34 | P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. ( Cronin, C; Gongora Nieto, M; Harrison, D; Jacobson, KA; Joshi, BV; Liang, BT; Shen, JB; Sonin, D, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borst, AJ | 1 |
| Tchapyjnikov, D | 1 |
| Mayengbam, S | 1 |
| Raposo, S | 1 |
| Aliani, M | 1 |
| House, JD | 1 |
| Sorolla, MA | 1 |
| Rodríguez-Colman, MJ | 1 |
| Vall-Llaura, N | 1 |
| Vived, C | 1 |
| Fernández-Nogales, M | 1 |
| Lucas, JJ | 1 |
| Ferrer, I | 1 |
| Cabiscol, E | 1 |
| Sarnak, MJ | 1 |
| Wang, SR | 1 |
| Beck, GJ | 1 |
| Kusek, JW | 1 |
| Selhub, J | 1 |
| Greene, T | 1 |
| Levey, AS | 1 |
| Shen, JB | 1 |
| Cronin, C | 1 |
| Sonin, D | 1 |
| Joshi, BV | 1 |
| Gongora Nieto, M | 1 |
| Harrison, D | 1 |
| Jacobson, KA | 1 |
| Liang, BT | 1 |
| Wang, XD | 1 |
| Kashii, S | 1 |
| Zhao, L | 1 |
| Tonchev, AB | 1 |
| Katsuki, H | 1 |
| Akaike, A | 1 |
| Honda, Y | 1 |
| Yamashita, J | 1 |
| Yamashima, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Department of Psychiatry, Taichung Veterans General Hospital[NCT04972643] | 163 participants (Actual) | Interventional | 2012-09-23 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pyridoxal phosphate and Disease Exacerbation
| Article | Year |
|---|---|
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cy | 2002 |
5 other studies available for pyridoxal phosphate and Disease Exacerbation
| Article | Year |
|---|---|
B
Topics: Child; Disease Progression; Hemophilia A; Hemorrhage; Humans; Male; Pyridoxal Phosphate; Seizures; V | 2018 |
Oral exposure to the anti-pyridoxine compound 1-amino D-proline further perturbs homocysteine metabolism through the transsulfuration pathway in moderately vitamin B₆ deficient rats.
Topics: Animals; Asymptomatic Diseases; Biomarkers; Cystathionine; Cystathionine gamma-Lyase; Diet; Disease | 2015 |
Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice.
Topics: Adult; Aged; Animals; Cerebral Cortex; Corpus Striatum; Cystathionine; Disease Models, Animal; Disea | 2016 |
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Benzenesulfonates; Ca | 2007 |
Vitamin B6 protects primate retinal neurons from ischemic injury.
Topics: Animals; Disease Models, Animal; Disease Progression; Ischemic Attack, Transient; Macaca; Neurons; O | 2002 |